Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 372

1.

The relationship of age with the clinical phenotype in multiple sclerosis.

Scalfari A, Lederer C, Daumer M, Nicholas R, Ebers GC, Muraro PA.

Mult Scler. 2016 Nov;22(13):1750-1758.

PMID:
26869531
2.

MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: no.

Ebers GC.

Mult Scler. 2014 Mar;20(3):282-3. doi: 10.1177/1352458513518264. No abstract available.

PMID:
24589686
3.

Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.

Guimond C, Lee JD, Ramagopalan SV, Dyment DA, Hanwell H, Giovannoni G, Criscuoli M, Yee IM, Vorobeychik G, Ebers GC, Sadovnick AD.

Mult Scler. 2014 Aug;20(9):1182-8. doi: 10.1177/1352458513519179.

PMID:
24414537
4.

Interactions of environment and genes in multiple sclerosis.

Ebers G.

J Neurol Sci. 2013 Nov 15;334(1-2):161-3. doi: 10.1016/j.jns.2013.08.018.

PMID:
24007873
5.

Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease.

Handel AE, Sandve GK, Disanto G, Berlanga-Taylor AJ, Gallone G, Hanwell H, Drabløs F, Giovannoni G, Ebers GC, Ramagopalan SV.

BMC Med. 2013 Jul 12;11:163. doi: 10.1186/1741-7015-11-163.

6.

Mortality in patients with multiple sclerosis.

Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC.

Neurology. 2013 Jul 9;81(2):184-92. doi: 10.1212/WNL.0b013e31829a3388. Review.

7.

DNA methylation in monozygotic quadruplets affected by type 1 diabetes.

Disanto G, Vcelakova J, Pakpoor J, Elangovan RI, Sumnik Z, Ulmannova T, Ebers GC, Ramagopalan SV, Stechová K.

Diabetologia. 2013 Sep;56(9):2093-5. doi: 10.1007/s00125-013-2972-3. No abstract available.

PMID:
23793775
8.

Inactive or moderately active human promoters are enriched for inter-individual epialleles.

Gemma C, Ramagopalan SV, Down TA, Beyan H, Hawa MI, Holland ML, Hurd PJ, Giovannoni G, Leslie RD, Ebers GC, Rakyan VK.

Genome Biol. 2013 May 25;14(5):R43. doi: 10.1186/gb-2013-14-5-r43.

9.

TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis.

Paltser G, Liu XJ, Yantha J, Winer S, Tsui H, Wu P, Maezawa Y, Cahill LS, Laliberté CL, Ramagopalan SV, DeLuca GC, Sadovnick AD, Astsaturov I, Ebers GC, Henkelman RM, Salter MW, Dosch HM.

Mol Med. 2013 Jul 24;19:149-59. doi: 10.2119/molmed.2012.00329.

10.

Month of birth and thymic output.

Disanto G, Watson CT, Meier UC, Ebers GC, Giovannoni G, Ramagopalan SV.

JAMA Neurol. 2013 Apr;70(4):527-8. doi: 10.1001/jamaneurol.2013.2116. No abstract available.

PMID:
23568650
11.

Onset of secondary progressive phase and long-term evolution of multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Muraro PA, Ebers GC.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):67-75. doi: 10.1136/jnnp-2012-304333.

PMID:
23486991
12.

Association of smoking with risk of multiple sclerosis: a population-based study.

Ramagopalan SV, Lee JD, Yee IM, Guimond C, Traboulsee AL, Ebers GC, Sadovnick AD.

J Neurol. 2013 Jul;260(7):1778-81. doi: 10.1007/s00415-013-6873-7.

PMID:
23455932
13.

Early relapses, onset of progression, and late outcome in multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC.

JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599.

PMID:
23407713
14.

A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Galea I, Lederer C, Neuhaus A, Muraro PA, Scalfari A, Koch-Henriksen N, Heesen C, Koepke S, Stellmann P, Albrecht H, Winkelmann A, Weber F, Bahn E, Hauser M, Edan G, Ebers G, Daumer M.

Eur J Neurol. 2013 Jul;20(7):1107-9. doi: 10.1111/ene.12016.

15.

Review: the role of vitamin D in nervous system health and disease.

DeLuca GC, Kimball SM, Kolasinski J, Ramagopalan SV, Ebers GC.

Neuropathol Appl Neurobiol. 2013 Aug;39(5):458-84. doi: 10.1111/nan.12020. Review.

PMID:
23336971
16.

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study.

Goodin DS, Ebers GC, Cutter G, Cook SD, O'Donnell T, Reder AT, Kremenchutzky M, Oger J, Rametta M, Beckmann K, Knappertz V.

BMJ Open. 2012 Nov 30;2(6). pii: e001972. doi: 10.1136/bmjopen-2012-001972.

17.

Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis.

Ragnedda G, Disanto G, Giovannoni G, Ebers GC, Sotgiu S, Ramagopalan SV.

PLoS One. 2012;7(10):e46730. doi: 10.1371/journal.pone.0046730.

18.

Interferon β for secondary progressive multiple sclerosis: a systematic review.

La Mantia L, Vacchi L, Rovaris M, Di Pietrantonj C, Ebers G, Fredrikson S, Filippini G.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):420-6. doi: 10.1136/jnnp-2012-303291. Review.

PMID:
22952326
19.

Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans.

Beyan H, Down TA, Ramagopalan SV, Uvebrant K, Nilsson A, Holland ML, Gemma C, Giovannoni G, Boehm BO, Ebers GC, Lernmark Å, Cilio CM, Leslie RD, Rakyan VK.

Genome Res. 2012 Nov;22(11):2138-45. doi: 10.1101/gr.134304.111.

20.

Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.

Lincoln MR, Ebers GC.

Ann Neurol. 2012 Sep;72(3):307-11. doi: 10.1002/ana.23605. No abstract available.

PMID:
22915153
Items per page

Supplemental Content

Support Center